Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Child dies of measles in New York’s first such death in 30 years

Abstract editorial illustration

A child in rural northern New York has succumbed to measles, marking the state's first such fatality in 30 years, state officials reported on Monday. The victim contracted the viral disease in Lewis County, situated approximately 93 miles north of Syracuse, according to Governor Kathy Hochul. Measles was effectively eradicated in the United States in 2000 through widespread vaccination efforts; however, vaccination rates have declined in recent years, falling below the critical 95% threshold necessary to avert outbreaks.

Governor Hochul emphasized that the child's death serves as a "devastating reminder of what's at stake when Washington deliberately erodes decades of progress in safeguarding Americans from preventable illnesses." The Centers for Disease Control and Prevention has documented three measles-related deaths in the U.S. this year, although state health departments have reported higher figures.

Pennsylvania health officials have recorded five fatalities this year and are investigating a possible sixth. In response to a surge in measles cases in neighboring states and rural areas of New York, Governor Hochul declared a disaster emergency in early October. The executive order broadened the pool of individuals authorized to administer measles vaccines to encompass paramedics, midwives, and other professionals, and it enabled nurses to order testing alongside doctors.

Written by urgent.news from Winnipeg Free Press's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 9 other outlets

Read the original at winnipegfreepress.com →

More in Health & Medicine

Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation

Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation.

  • King's College London scientists developed KCL-286 drug for Alzheimer's.
  • KCL-286 repairs DNA damage, reduces brain inflammation, targets multiple aspects.
  • Drug activates retinoic acid pathway protein, could speed up drug development.

More from Tuesday 3 November →